SCHEMBL7168282

SCHEMBL7168282

NCC1=Nc2cc(F)ccc2OC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.46
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
HTT P42858 2/20 0.46
KDM4E B2RXH2 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
THRB P10828 1/20 0.35
NOTUM Q6P988 1/20 0.34
ALDH1A1 P00352 3/20 0.33
GAA P10253 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
ALOX12 P18054 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7170230 0.74 SMN1; SMN2 (0.45) MAPTNPC1RAB9AHTTKDM4E
SCHEMBL24244089 0.74 SMN1; SMN2 (0.41) MAPTNPC1RAB9AHTTKDM4E
SCHEMBL12206691 0.69 MAPT (0.84) MAPTNPC1RAB9AHTTKDM4E
SCHEMBL12206704 0.69 MAPT (0.78) MAPTNPC1RAB9AHTTKDM4E
SCHEMBL5541689 0.67 MAPT (0.38) MAPTNPC1RAB9AHTTTHRB
SCHEMBL16806550 0.63 MAPT (1.00) MAPTNPC1RAB9AHTTKDM4E
SCHEMBL7450874 0.59 MAPT (0.38) MAPTNPC1RAB9AHTTKDM4E
Hydrochloric Acid SCHEMBL15818842 0.59 FABP6 (0.39) MAPTNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL30089882 0.59 NPC1 (0.38) MAPTNPC1RAB9AHTTKDM4E
SCHEMBL3152242 0.58 MEN1 (0.59) MAPTNPC1RAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6573377-B1 Antitumor agent capable of showing its efficacy even against 5- FU drug resistant tumors DAIICHI PHARMACEUTICALS CO., LTD. (JP) 2003-06-03 US disclosed
US-6552018-B1 As antitumor agents DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-04-22 US disclosed
EP-1103551-A1 PYRAZOLE DERIVATIVES AND SALTS THEREOF DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-05-30 EP disclosed
US-6169086-B1 AN ANTITUMOR AGENT FOR TREATING TUMOR RESISTANT TO 5-FLUOROURACIL TYPE DRUGS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed